The results indicated that although linopirdine reduced cell proliferation at 24 h, there was no significant change in overall cell viability, when treated with OM containing the KV7.3 blockers or the KV7 opener (Figure 5B). This evidence concerns the gene KCNQ3 and ocular melanoma.